Pharmaceutical Drug Targets and Diseases: Difference between revisions
Jump to navigation
Jump to search
David Canner (talk | contribs) No edit summary |
David Canner (talk | contribs) No edit summary |
||
| Line 9: | Line 9: | ||
***[[Acetylcholinesterase]] | ***[[Acetylcholinesterase]] | ||
***[[2ace|Acetylcholinesterase from Torpedo Californica]] | ***[[2ace|Acetylcholinesterase from Torpedo Californica]] | ||
***[[Flexibility of aromatic residues in acetylcholinesterase|Flexibility | ***[[SANDBOX138|Human APP Intracellular Domain Complex with Fe65-PTB2]] | ||
***[[Flexibility of aromatic residues in acetylcholinesterase|Aromatic Residue Flexibility in AChE]] | |||
***[[Beta Amyloid]] | ***[[Beta Amyloid]] | ||
***[[Acetylcholine binding protein]] (AChBP) | ***[[Acetylcholine binding protein]] (AChBP) | ||